Editorial: Sphingolipid metabolism dysfunction in cancer

Rashika El Ridi; Jingjing Duan; Junfei Jin

doi:10.3389/fendo.2023.1208616

Editorial: Sphingolipid metabolism dysfunction in cancer

Front Endocrinol (Lausanne). 2023 Jun 9:14:1208616. doi: 10.3389/fendo.2023.1208616. eCollection 2023.

Authors

Rashika El Ridi¹, Jingjing Duan², Junfei Jin³

Affiliations

¹ Zoology Department, Faculty of Science, Cairo University, Giza, Egypt.
² Human Aging Research Institute and School of Life Sciences, Nanchang University, Nanchang, China.
³ Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, Affiliated Hospital of Guilin Medical University, Guilin, China.

No abstract available

Keywords: cancer; endocrine disorder; mechanism; metabolism; sphingolipid.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Lipid Metabolism
Neoplasms* / metabolism
Sphingolipids / metabolism

Substances

Sphingolipids

Grants and funding

This work was supported in part by the Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department (ZY21195024), and the third batch of Lijiang Scholar Award in Guilin (2022-5-07).